Code of Maryland Regulations (Last Updated: April 6, 2021) |
Title 10. Maryland Department of Health |
Part 4. |
Subtitle 27. BOARD OF NURSING |
Chapter 10.27.03. Nursing Education Programs |
Sec. 10.27.03.12. Resources, Facilities, and Services
-
A. Physical Facilities. The physical facilities shall be adequate to meet the needs of the nursing program and include the following:
(1) Office for the administrator, faculty members, and staff;
(2) Adequate space for privacy of faculty-student conferences;
(3) Classroom, laboratories, simulation laboratories, and conference rooms;
(4) Space for equipment and instructional materials; and
(5) Space for noninstructional activities of nursing faculty and students.
B. Learning resources shall be developed with faculty input and shall be:
(1) Accessible to faculty and students;
(2) Comprehensive; and
(3) Current.
C. Educational support services that facilitate students' abilities to achieve the program's objectives, outcomes, or competencies shall be available.
D. Cooperating Clinical Agencies.
(1) The appropriate authorities shall approve cooperating clinical agencies and all facilities used for clinical learning experiences.
(2) Facilities with conditional or provisional approval status may not be used for student learning experiences.
(3) Cooperating clinical agencies shall meet the following requirements:
(a) Accreditation or approval by the appropriate authority;
(b) A sufficient number and variety of clients to provide learning experiences for all students to achieve the stated objectives, outcomes, or competencies;
(c) A sufficient number of registered nurses and other nursing personnel to ensure safe and continuous care of clients; and
(d) Conformance with accepted standards of nursing care and practice.
E. Written Agreements.
(1) Written agreements between the program and the cooperating clinical agencies shall specify the responsibility of the program to the cooperating clinical agency and the responsibility of the cooperating clinical agency to the program.
(2) Written agreements shall:
(a) Be developed jointly with the cooperating clinical agency;
(b) Be reviewed periodically; and
(c) Include provision for adequate notice of termination.